ERA: Semaglutide Improves Health-Related QoL in Adults With T2D, CKD

TUESDAY, June 9, 2026-- For adults with type 2 diabetes and chronic kidney disease, two years of semaglutide treatment improves health-related quality of life (QoL) versus placebo, according to a study presented at the annual congress of the...